| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,661 |
32,028 |
$2.20M |
| 99442 |
|
5,002 |
4,407 |
$375K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,571 |
2,552 |
$234K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,829 |
1,820 |
$162K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,103 |
1,038 |
$74K |
| 99205 |
Prolong outpt/office vis |
513 |
513 |
$72K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,468 |
1,521 |
$35K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,057 |
1,010 |
$34K |
| 99385 |
|
323 |
320 |
$32K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
786 |
734 |
$22K |
| 87428 |
|
392 |
374 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,491 |
701 |
$17K |
| 93000 |
|
1,022 |
1,004 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
889 |
748 |
$8K |
| 90688 |
|
483 |
473 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
561 |
538 |
$5K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
418 |
101 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
447 |
435 |
$5K |
| 99397 |
|
51 |
49 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
34 |
33 |
$3K |
| 99490 |
Ccm add 20min |
445 |
432 |
$2K |
| 90686 |
|
91 |
91 |
$2K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
286 |
278 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
44 |
40 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
301 |
265 |
$727.21 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
27,754 |
20,620 |
$674.27 |
| 99441 |
|
58 |
57 |
$640.28 |
| 90658 |
|
37 |
37 |
$514.94 |
| 99443 |
|
13 |
12 |
$474.14 |
| 99306 |
Prolong nursin fac eval 15m |
18 |
18 |
$172.01 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
56 |
53 |
$121.72 |
| 87807 |
|
23 |
21 |
$78.14 |
| G0008 |
Administration of influenza virus vaccine |
88 |
84 |
$73.96 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
58 |
32 |
$5.32 |
| 3078F |
|
285 |
259 |
$1.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
20,385 |
15,403 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
261 |
247 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
14,254 |
10,998 |
$0.00 |
| 3077F |
|
49 |
43 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
12 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,644 |
4,642 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
7,237 |
5,754 |
$0.00 |
| 3079F |
|
85 |
82 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
258 |
246 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
186 |
154 |
$0.00 |
| 3074F |
|
314 |
285 |
$0.00 |
| 3080F |
|
14 |
12 |
$0.00 |
| 3075F |
|
20 |
19 |
$0.00 |